EarningsQ4 2023 Earnings Report

Eledon Pharmaceuticals (2TK) Q4 2023 Earnings Report

1 Followers

DE:2TK Q4 2023 EPS Results

Actual EPS-€0.28

Consensus EPS-€0.32

Beat/MissBeat by +€0.03

One Year Ago EPS-€3.64

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ4 2023

Date03/28/2024

TimeAfter Close

Conference CallThursday, March 28, 2024

DE:2TK Upcoming Earnings

Eledon Pharmaceuticals's next earnings date is estimated for November 18, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 18, 2026	2026 (Q3)	-0.17 / -	-0.187	―
Aug 13, 2026	2026 (Q2)	-0.14 / -0.24	-0.116	-107.69% (-0.12)
May 13, 2026	2026 (Q1)	-0.16 / -0.29	-0.071	-312.50% (-0.22)
Mar 19, 2026	2025 (Q4)	-0.18 / -0.10	-0.57	82.81% (+0.47)
Nov 14, 2025	2025 (Q3)	-0.22 / -0.19	-0.285	34.38% (+0.10)
Aug 14, 2025	2025 (Q2)	-0.20 / -0.12	-0.944	87.74% (+0.83)
May 14, 2025	2025 (Q1)	-0.23 / -0.07	-0.303	76.47% (+0.23)
Mar 20, 2025	2024 (Q4)	-0.28 / -0.57	-0.285	-100.00% (-0.28)
Nov 12, 2024	2024 (Q3)	-0.28 / -0.28	-0.312	8.57% (+0.03)
Aug 08, 2024	2024 (Q2)	-0.27 / -0.32	-0.356	10.00% (+0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed